Clinical Trials Browser

Phase 1/2 × Tiragolumab × 30 days × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Phase 1/2 Recruiting

Advanced Liver Cancers

NCT05286801 2026-05-13

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Phase 1/2 Active not recruiting

Chordoma, Sarcoma, Rhabdoid Tumor

NCT03337698 2026-05-12

Morpheus Lung

Phase 1/2 Terminated

314 enrolled 31 charts

Carcinoma, Non-Small-Cell Lung